FDA Inspection 1258442 — SOLA Pharmaceuticals LLC
The FDA completed an inspection of SOLA Pharmaceuticals LLC on January 8, 2025 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 8, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baton Rouge, LA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)